Navigation Links
Halozyme and Intrexon Announce Collaboration to Develop First Subcutaneous Recombinant Alpha 1-Antitrypsin Replacement Therapy
Date:6/6/2011

SAN DIEGO and FOSTER CITY, Calif., June 6, 2011 /PRNewswire/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO) and Intrexon Corporation, today announced the signing of a worldwide exclusive licensing agreement for the use of rHuPH20 (recombinant human hyaluronidase) in the development of a subcutaneous (under the skin) injectable formulation of Intrexon Corporation's recombinant human alpha 1-antitrypsin (rHuA1AT). Under terms of the agreement, Halozyme may receive up to $63 million, commencing with an upfront payment of $9 million and total potential future milestone payments of $54 million dependent upon the achievement of clinical and regulatory targets, plus up to 11% royalty on future sales of the combination of rHuA1AT with rHuPH20. The license provides Intrexon Corporation, a next generation synthetic biology company, with exclusivity to alpha 1-antitrypsin, for the indications resulting from A1AT deficiency. Additional terms of the transaction have not been disclosed.

(Logo:  http://photos.prnewswire.com/prnh/20110606/LA14886LOGO)

(Logo:  http://photos.prnewswire.com/prnh/20100302/LA63139LOGO)

Alpha 1-antitrypsin is a protease inhibitor that provides a protective effect from inflammatory cell proteases, especially neutrophil elastase. Intrexon is using its synthetic DNA platform for high-level expression of recombinant A1AT for the potential treatment of diseases resulting from genetic alpha 1-antitrypsin deficiency such as genetic emphysema. A1AT may also benefit patients with chronic obstructive pulmonary disease (COPD) and cystic fibrosis. Currently there is no A1AT recombinant protein available and,
'/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Halozyme Therapeutics and ViroPharma Announce $83 Million Global Licensing Agreement to Develop Subcutaneous Cinryze® (C1 esterase inhibitor [human])
2. ViroPharma and Halozyme Announce Collaboration for Combination of Recombinant Human Hyaluronidase Enzyme (rHuPH20) Technology with C1 Esterase Inhibitor
3. Halozyme Therapeutics to Present at the Bank of America Merrill Lynch Health Care Conference on May 12
4. Halozyme Therapeutics to Host First Quarter 2011 Financial Results Conference Call on May 6
5. Halozyme Therapeutics Reports Fourth Quarter and Year End 2010 Financial Results
6. Halozyme Therapeutics to Host Fourth Quarter and 2010 Financial Results Conference Call on March 11
7. Halozyme Therapeutics to Present at J.P. Morgan Healthcare Conference on January 12
8. Halozyme Therapeutics Realigns Management
9. Halozymes rHuPH20 With Recombinant Human Insulin Demonstrates Glycemic Control Comparable to Lispro
10. Halozyme Therapeutics Announces Implementation of Development Focused Strategy
11. Halozyme Therapeutics to Host Analyst Meeting on October 14 in New York
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... July 29, 2014 New technology in the ... allow physicians to see and assess brain tissue more ... to study authors who released their findings today at ... Annual Meeting in Colorado Springs, CO. ... field of neurointervention, a specialty that facilitates stroke treatment ...
(Date:7/29/2014)... HILL, Conn. , July 29, 2014 Numotion,s ... 2014, Mike Swinford will be the company,s new ... a highly successful 22-year career at GE where he worked ... million in annual revenue to over $5 billion. His most ... Global Services. "I am thrilled to join ...
(Date:7/29/2014)... Fla. , July 29, 2014 /PRNewswire-iReach/ -- ... service provider, has launched its Medical Equipment ...  These services are tailored to the cruise ... standards prompted industry operators to propose that they ... MHG Medical,s new program is intended to create ...
Breaking Medicine Technology:New Technology May Improve Visualization Of The Brain During Stroke Treatment 2New Technology May Improve Visualization Of The Brain During Stroke Treatment 3Numotion Names Mike Swinford CEO 2MHG Medical Management Services Aims to Change Cruise Industry Standard With New Equipment Maintenance Program 2
... NHS National Innovation Centre supports the cost ... Medical announced today the findings of an independent economic ... Innovation Centre, the NHS organization which supports innovators, commissioners, ... of innovations that will benefit the NHS. ...
... --  Janet R. Dees, CEO/President of American Vascular Access, ... newest vascular access center in Columbus, Georgia.  "Our Newnan, ... Vascular Access, LLC., and the addition of the Columbus, ... "Our goal has continued to be to ...
Cached Medicine Technology:NHS National Innovation Centre Estimates Sequana Medical's ALFApump® System Could Save the NHS £50 Million in ascites Care Annually 2American Vascular Access Continues Growth in Georgia 2
(Date:7/30/2014)... NY (PRWEB) July 30, 2014 Running ... Dr Steven Shoshany aims to help runners keep ... techniques to help athletes continue training. He has recently ... ART (Active Release Techniques), Cold Laser Therapy, Graston technique ... injury free. , Dr Shoshany often combines ...
(Date:7/30/2014)... AttorneyOne.com, a recognized authority on law, ... from the FDA on snacks . , Dancing ... are recalled because they contain organic Carob ... salmonella. Salmonella can cause serious, fatal infections in people ... cause abdominal pain, vomiting, nausea, diarrhea, or fever. In ...
(Date:7/30/2014)... The Diabetes Daily Grind had its ... and Ryan Fightmaster hope to gain attention for the ... July 26th of this year, Clour and Fightmaster started ... the diabetic life. By sharing stories on their ... believe other diabetics will find ways to live with ...
(Date:7/30/2014)... July 30, 2014 An interesting fact ... community where motorcycle enthusiasts congregate, BikerKiss.com . The ... that were revealed by BikerKiss indicate that women motorcycle ... past 3 years. , Members on BikerKiss are mostly ... Australia and some other European countries who are there ...
(Date:7/30/2014)... 30, 2014 According to the Nasal Polyps ... a comprehensive guide that teaches people how to cure their ... book uncovers to readers the horrible truth about conventional treatments ... that inside this book, people will learn how to prevent ... asthma, and nasal infections. , Nasal Polyps Treatment Miracle, as ...
Breaking Medicine News(10 mins):Health News:Chiropractor Helping Runners Keep Going with New Integrated Treatment Protocols 2Health News:Chiropractor Helping Runners Keep Going with New Integrated Treatment Protocols 3Health News:Various Snacks by Dancing Star Recalled: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Various Snacks by Dancing Star Recalled: AttorneyOne Monitors and Keeps Consumers Informed 3Health News:Strangers Come Together to Form Diabetes Website: Real Messages of Hope and Inspiration 2Health News:Single Women Motorcycle Riders In Rapid Increase 2Health News:Nasal Polyps Treatment Miracle Book Review Exposes Manuel Richards' Guide For Treating Nasal Polyps – Vkool.com 2Health News:Nasal Polyps Treatment Miracle Book Review Exposes Manuel Richards' Guide For Treating Nasal Polyps – Vkool.com 3
... ... ... ... HOUSTON , March 1 Despite Northstar management,s recent claim ...
... ... on Executive Position , ... Tucson, Ariz. (Vocus) February 28, 2010 -- Tom Rios has been promoted to ... Most recently, he had been Splendido’s director of accounting., , ,Rios will work with ...
... ... ... ... ...
... ... ... ... , , ...
... ... ... ... ...
... Researchers from The University of Texas M. D. Anderson ... measure the severity of symptoms that can complicate stem ... graft-versus-host disease (cGVHD), and was presented with supporting research ... cGVHD - a chronic disease that requires ...
Cached Medicine News:Health News:Northstar Management Forecasts a Loss of $1.2 Million for 2010 at Its Palladium for Surgery -- Houston, Ltd. Centre 2Health News:Tom Rios Named Executive Director at Splendido 2Health News:AMA: Physicians Outraged at Today's Steep Medicare Cut 2Health News:AMA: Physicians Outraged at Today's Steep Medicare Cut 3Health News:AMA: Physicians Outraged at Today's Steep Medicare Cut 4Health News:AMA: Physicians Outraged at Today's Steep Medicare Cut 5Health News:AMA: Physicians Outraged at Today's Steep Medicare Cut 6Health News:AMA: Physicians Outraged at Today's Steep Medicare Cut 7Health News:HCA Announces Offering of $1.0 Billion Senior Secured First Lien Notes 2Health News:HCA Announces Offering of $1.0 Billion Senior Secured First Lien Notes 3Health News:HCA Announces Offering of $1.0 Billion Senior Secured First Lien Notes 4Health News:Aflac Incorporated to Present at the Raymond James 31st Annual Institutional Investors Conference 2Health News:Aflac Incorporated to Present at the Raymond James 31st Annual Institutional Investors Conference 3Health News:Aflac Incorporated to Present at the Raymond James 31st Annual Institutional Investors Conference 4Health News:Aflac Incorporated to Present at the Raymond James 31st Annual Institutional Investors Conference 5Health News:M. D. Anderson develops tool to measure severity of chronic graft-vs.-host disease symptoms 2Health News:M. D. Anderson develops tool to measure severity of chronic graft-vs.-host disease symptoms 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: